Fig. 5: A2AR positive CD8+ T cells exhibit decreased expression of STAT5 target genes prior to treatment with anti-PD-L1.

A2AR eGFP reporter mice were injected with 5 × 105 AT-3 ova tumors subcutaneously and were indicated treated at days 14 and 18 post-tumor inoculation with anti-PD-L1. At day 21 post tumor inoculation CD8+ tumor-infiltrating lymphocytes were analyzed by 3’RNA-sequencing. Biological samples were pooled from n = 3 mice per replicate. Data represented as mean ± SD. A Principle component analysis based on the top 100 most variable genes. B Normalized CPMs for Adora2a expression from CD8+GFP− (n = 3) and CD8+GFP+ (n = 2) cells. C–E Gene set enrichment analysis or heatmap of gene expression for indicated pathways comparing CD8+A2AR+ and CD8+A2AR- cells. Raw P values are shown. Source data are provided as a Source Data file.